ArticleMolecular diversity2014

Pyrid-2-yl and 2-CyanoPhenyl fused heterocyclic compounds as human P2X3 inhibitors: a combined approach based on homology modelling, docking and QSAR analysis.

Sridhara Janardhan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.